175
Participants
Start Date
August 24, 2018
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Metformin
Metformin ER 500 mg daily, titrated at 1 month intervals to 500 mg twice daily, then 750 mg twice daily, as tolerated, for 2 years.
Lifestyle/Risk Factor Modification
Diet/nutrition counseling and exercise prescription with follow-up visits, sleep apnea screening and treatment if detected, optimization of guideline-directed medical therapies for hypertension, coronary artery disease (CAD), hyperlipidemia and heart failure (HF).
Cleveland Clinic, Cleveland
American Heart Association
OTHER
The Cleveland Clinic
OTHER
Mina Chung, MD
OTHER